A laboratory with substance.
Target a business with repeat customers, strong scientific leadership, defensible records and sound underlying economics.
Analytical science & research infrastructure
PSIQI is developing a laboratory platform through acquisition, with a focus on analytical science.
Pre-acquisition thesis Colorado focus

A platform built on evidence.
Existing operationsScientific disciplineMeasured expansionThe starting point
Begin with the people, relationships and operating systems of an established laboratory. Earn the right to expand through reliable work and demonstrated demand.
Target a business with repeat customers, strong scientific leadership, defensible records and sound underlying economics.
Invest in methods, documentation and service delivery. Preserve the expertise that makes the laboratory valuable.
Evaluate specialized research services when customers, capability and the regulatory pathway support the investment.

The operating philosophy
Useful science depends on more than an instrument. It depends on the method, the record, the person reviewing the result, and the consistency of the work.
That is the operating foundation PSIQI aims to build.
Explore the business modelThe proposed path
Each expansion is a separate decision.
Every decision needs evidence.
Retain existing customers, scientific talent and quality systems. Underwrite the acquisition on verified operating economics.
Evaluate method development, stability and related analytical projects that fit the lab's capabilities and customer needs.
Assess controlled research services only within a defined lawful scope, with appropriate scientific and quality leadership.
Compare specialist partnerships and owned capability for future pharmaceutical ingredient development. Manufacturing is a separate investment case.
Research notes
Regulatory context · July 2026
A more current foundation for discussing clinical development and its requirements.
Read contextClinical development · November 2026
Compass reported its COMP360 submission. The distinction between submission and approval still matters.
Read contextBuild the foundation with us
For investors, laboratory owners and scientific partners.
info@psiqi.com